Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine

• Үндсэн зохиолчид: William R. Lykins (Зохиогч), Jeroen Pollet (Зохиогч), Jessica A. White (Зохиогч), Brian Keegan (Зохиогч), Leroy Versteeg (Зохиогч), Ulrich Strych (Зохиогч), Wen-Hsiang Chen (Зохиогч), Raodoh Mohamath (Зохиогч), Gabi Ramer-Denisoff (Зохиогч), Sierra Reed (Зохиогч), Samuel Beaver (Зохиогч), Alana Gerhardt (Зохиогч), Emily A. Voigt (Зохиогч), Mark A. Tomai (Зохиогч), Robert Sitrin (Зохиогч), Robert K. M. Choy (Зохиогч), Frederick J. Cassels (Зохиогч), Peter J. Hotez (Зохиогч), Maria Elena Bottazzi (Зохиогч), Christopher B. Fox (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Introduction: Since their introduction, adjuvanted recombinant subunit vaccines against COVID-19 have played a pivotal role in protecting global populations. Optimizing the immune response's quality, amplitude, and durability to these vaccines depends on the appropriate adjuvant choice and dose...